Scientists develop nanomaterial that targets cancer cells while sparing healthy tissue
SMRTR summary
Oregon State University researchers created an iron-based nanomaterial that successfully eliminated breast cancer tumors in mice by generating two types of toxic oxygen compounds simultaneously, overcoming limitations of existing chemodynamic therapies that produce only one type. The treatment caused complete tumor regression without recurrence or severe side effects, though significant development remains before human clinical trials.
SMRTR provides this summary for quick context. The original article belongs to TechSpot.
Read the original article